Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

7.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Survival Tree01:19

Survival Tree

502
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
502

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A framework for assessing algorithmic discrimination risks in training data: a case of pediatric type 1 diabetes.

JAMIA open·2026
Same author

European foulbrood disease and protein supplementation in honey bee (<i>Apis mellifera</i> L.) colonies pollinating highbush blueberries in British Columbia.

PeerJ·2026
Same author

Correction: mHealth intervention to improve quality of life in patients with chronic diseases during the COVID-19 crisis in Paraguay: A study protocol for a randomized controlled trial.

PloS one·2026
Same author

Clinical Outcomes Associated with the Use of a Family-Based Digital Support Program in Patients with Pharmacologic Treatment for Obesity.

Journal of clinical medicine·2026
Same author

Enhancing Adherence and Mental Well-Being in Pediatric Growth Hormone Therapy: Feasibility Prospective Observational Study of a Family-Centered Digital Companion.

JMIR pediatrics and parenting·2025
Same author

Correction: Digital Health Program to Support Family Caregivers of Children Undergoing Growth Hormone Therapy: Qualitative Feasibility Study.

JMIR pediatrics and parenting·2025

Related Experiment Video

Updated: Apr 15, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Disparate Model Performance and Stability in Machine Learning Clinical Support for Diabetes and Heart Diseases.

Ioannis Bilionis1,2, Ricardo C Berrios1, Luis Fernandez-Luque1

  • 1Adhera Health, Santa Cruz, USA.

AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|June 12, 2025
PubMed
Summary

Machine learning (ML) models show sex and age biases in chronic disease prediction. Addressing model arbitrariness, not just data representation, is crucial for equitable clinical decision-making.

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

548

Related Experiment Videos

Last Updated: Apr 15, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.7K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

548

Area of Science:

  • Biomedical Informatics
  • Artificial Intelligence in Healthcare
  • Health Equity

Background:

  • Machine learning (ML) algorithms are increasingly used for clinical decision-making.
  • Underrepresentation of demographic groups in training data can lead to performance disparities.
  • Existing research highlights potential inequities in ML models for chronic diseases.

Purpose of the Study:

  • To investigate sex- and age-related inequities in chronic disease datasets and ML models.
  • To introduce a novel analytical framework to assess model arbitrariness beyond traditional metrics.
  • To evaluate the impact of data representativeness and model arbitrariness on predictive accuracy.

Main Methods:

  • Analysis of chronic disease data from over 25,000 individuals.
  • Application of a novel framework combining systematic arbitrariness with accuracy and data complexity metrics.
  • Evaluation of ML model performance across different demographic groups (sex and age).

Main Results:

  • Mild sex-related disparities observed, with higher predictive accuracy for males.
  • Significant age-related differences found, favoring younger patients.
  • Older patients exhibited inconsistent predictive accuracy, correlated with higher data complexity and lower model performance.

Conclusions:

  • Data representativeness alone does not ensure equitable ML outcomes in healthcare.
  • Model arbitrariness is a significant factor contributing to performance disparities.
  • Addressing model arbitrariness is essential before clinical deployment of ML tools.